Noonan Syndrome-associated SHP-2/Ptpn11 Mutants Enhance SIRPα and PZR Tyrosyl Phosphorylation and Promote Adhesion-mediated ERK Activation
Open Access
- 30 May 2008
- journal article
- Published by Elsevier BV
- Vol. 283 (22), 15328-15338
- https://doi.org/10.1074/jbc.m801382200
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Protein tyrosine phosphatase function: the substrate perspectiveBiochemical Journal, 2007
- SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growthThe Journal of cell biology, 2006
- Diverse Biochemical Properties of Shp2 MutantsJournal of Biological Chemistry, 2005
- Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemiaJournal of Human Genetics, 2005
- Novel mesenchymal and haematopoietic cell isoforms of the SHP-2 docking receptor, PZR: identification, molecular cloning and effects on cell migrationBiochemical Journal, 2003
- Spectrum of mutations in PTPN11 and genotype–phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndromeEuropean Journal of Human Genetics, 2003
- Role of SHP-2 in Fibroblast Growth Factor Receptor-Mediated Suppression of Myogenesis in C2C12 MyoblastsMolecular and Cellular Biology, 2002
- The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factorsOncogene, 2001
- Dissecting the Interaction of SHP-2 with PZR, an Immunoglobulin Family Protein Containing Immunoreceptor Tyrosine-based Inhibitory MotifsPublished by Elsevier BV ,2000
- Characterization of a 115-kDa Protein That Binds to SH-PTP2, a Protein-tyrosine Phosphatase with Src Homology 2 Domains, in Chinese Hamster Ovary CellsPublished by Elsevier BV ,1996